Ocular Therapeutix Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 45.47. In total, the insiders bought 9.66M and sold 1.84M OCUL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
45.47 |
| ● Buy | 9.66M shares |
| ● Sell | 1.84M shares |
|
55% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Oct 08, 2025 Sell |
Anderman Todd Chief Legal Officer |
11 132 Value: $137.4K |
||
|
Oct 08, 2025 Sell |
Anderman Todd Chief Legal Officer |
11 132 Value: $137.4K |
||
|
Oct 02, 2025 Sell |
Kaiser Peter Chief Development Officer |
9 653 Value: $106.5K |
||
|
Oct 02, 2025 Sell |
Heier Jeffrey S. Chief Scientific Officer |
10 502 Value: $115.9K |
||
|
Oct 02, 2025 Sell |
Heier Jeffrey S. Chief Scientific Officer |
10 502 Value: $115.9K |
||
|
Oct 02, 2025 Sell |
Kaiser Peter Chief Development Officer |
9 653 Value: $106.5K |
||
|
Sep 09, 2025 Sell |
Dugel Pravin See Remarks |
49 754 Value: $0 |
||
|
Sep 09, 2025 Buy |
Dugel Pravin See Remarks |
49 754 Value: $634.9K |
||
|
Sep 09, 2025 Buy |
Dugel Pravin See Remarks |
49 754 Value: $634.9K |
||
|
Sep 09, 2025 Sell |
Dugel Pravin See Remarks |
49 754 Value: $0 |
||
|
Sep 02, 2025 Sell |
Notman Donald See Remarks |
1 066 Value: $13.3K |
||
|
Sep 02, 2025 Sell |
Notman Donald See Remarks |
1 066 Value: $13.3K |
||
|
Aug 25, 2025 Sell |
Kaiser Peter Chief Development Officer |
3 011 Value: $36.3K |
||
|
Aug 25, 2025 Sell |
Nayak Sanjay Chief Strategy Officer |
1 885 Value: $22.7K |
||
|
Aug 25, 2025 Sell |
Heier Jeffrey S. Chief Scientific Officer |
3 063 Value: $36.9K |
||
|
Aug 25, 2025 Sell |
Dugel Pravin See Remarks |
21 494 Value: $258.8K |
||
|
Aug 25, 2025 Sell |
Dugel Pravin See Remarks |
21 494 Value: $258.8K |
||
|
Aug 25, 2025 Sell |
Heier Jeffrey S. Chief Scientific Officer |
3 063 Value: $36.9K |
||
|
Aug 25, 2025 Sell |
Nayak Sanjay Chief Strategy Officer |
1 885 Value: $22.7K |
||
|
Aug 25, 2025 Sell |
Kaiser Peter Chief Development Officer |
3 011 Value: $36.3K |
||
|
Aug 12, 2025 Buy |
Waheed Nadia Chief Medical Officer |
40 363 Value: $503.7K |
||
|
Aug 12, 2025 Buy |
Waheed Nadia Chief Medical Officer |
122 923 Value: $1.53M |
||
|
Aug 12, 2025 Buy |
Waheed Nadia Chief Medical Officer |
122 923 Value: $1.53M |
||
|
Aug 12, 2025 Buy |
Waheed Nadia Chief Medical Officer |
40 363 Value: $503.7K |
||
|
Aug 11, 2025 Buy |
Dugel Pravin See Remarks |
250 361 Value: $3.14M |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
Sign In
Buy OCUL